310 related articles for article (PubMed ID: 17252290)
1. Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread.
Schwab JH; Boland P; Guo T; Brennan MF; Singer S; Healey JH; Antonescu CR
Ann Surg Oncol; 2007 Apr; 14(4):1507-14. PubMed ID: 17252290
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
[TBL] [Abstract][Full Text] [Related]
3. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
[TBL] [Abstract][Full Text] [Related]
4. Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging.
Schwab JH; Boland PJ; Antonescu C; Bilsky MH; Healey JH
Cancer; 2007 Oct; 110(8):1815-22. PubMed ID: 17724681
[TBL] [Abstract][Full Text] [Related]
5. Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma.
Rivero ER; Mesquita RA; de Sousa SC; Nunes FD
Ann Diagn Pathol; 2006 Feb; 10(1):36-8. PubMed ID: 16414544
[TBL] [Abstract][Full Text] [Related]
6. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
[TBL] [Abstract][Full Text] [Related]
7. Myxoid liposarcoma with EWS-CHOP type 1 fusion gene.
Suzuki K; Matsui Y; Endo K; Kubo T; Hasegawa T; Kimura T; Ohtani O; Yasui N
Anticancer Res; 2010 Nov; 30(11):4679-83. PubMed ID: 21115923
[TBL] [Abstract][Full Text] [Related]
8. Metastatic patterns of extremity myxoid liposarcoma and their outcome.
Estourgie SH; Nielsen GP; Ott MJ
J Surg Oncol; 2002 Jun; 80(2):89-93. PubMed ID: 12173385
[TBL] [Abstract][Full Text] [Related]
9. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
[TBL] [Abstract][Full Text] [Related]
10. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
Fiore M; Grosso F; Lo Vullo S; Pennacchioli E; Stacchiotti S; Ferrari A; Collini P; Lozza L; Mariani L; Casali PG; Gronchi A
Cancer; 2007 Jun; 109(12):2522-31. PubMed ID: 17510918
[TBL] [Abstract][Full Text] [Related]
11. Molecular variability of TLS-CHOP structure shows no significant impact on the level of adipogenesis: a comparative ultrastructural and RT-PCR analysis of 14 cases of myxoid/round cell liposarcomas.
Huang HY; Antonescu CR
Ultrastruct Pathol; 2003; 27(4):217-26. PubMed ID: 12907366
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.
ten Heuvel SE; Hoekstra HJ; van Ginkel RJ; Bastiaannet E; Suurmeijer AJ
Ann Surg Oncol; 2007 Jan; 14(1):222-9. PubMed ID: 17058128
[TBL] [Abstract][Full Text] [Related]
13. Specificity of fusion genes in adipocytic tumors.
Kubo T; Matsui Y; Naka N; Araki N; Myoui A; Endo K; Yasui N; Ohtani O; Suzuki K; Kimura T; Yoshikawa H; Ueda T
Anticancer Res; 2010 Feb; 30(2):661-4. PubMed ID: 20332486
[TBL] [Abstract][Full Text] [Related]
14. Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion.
Bode-Lesniewska B; Frigerio S; Exner U; Abdou MT; Moch H; Zimmermann DR
Genes Chromosomes Cancer; 2007 Nov; 46(11):961-71. PubMed ID: 17647282
[TBL] [Abstract][Full Text] [Related]
15. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
16. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.
Rapp TB; Yang L; Conrad EU; Mandahl N; Chansky HA
J Orthop Res; 2002 Jul; 20(4):723-9. PubMed ID: 12168660
[TBL] [Abstract][Full Text] [Related]
17. [Molecular diagnosis of liposarcomas: identification of the chimeric genes FUS/CHOP and EWS/CHOP].
Kekeeva TV; Riazantseva AA; Anreeva IuIu; Zavalishina LE; Babenko OV; Zaletaev DV; Petrov AN; Frank GA
Arkh Patol; 2009; 71(5):32-5. PubMed ID: 19938700
[TBL] [Abstract][Full Text] [Related]
18. Genomic PCR detects tumor cells in peripheral blood from patients with myxoid liposarcoma.
Panagopoulos I; Aman P; Mertens F; Mandahl N; Rydholm A; Bauer HF; Mitelman F
Genes Chromosomes Cancer; 1996 Oct; 17(2):102-7. PubMed ID: 8913727
[TBL] [Abstract][Full Text] [Related]
19. A novel FUS/CHOP chimera in myxoid liposarcoma.
Panagopoulos I; Mertens F; Isaksson M; Mandahl N
Biochem Biophys Res Commun; 2000 Dec; 279(3):838-45. PubMed ID: 11162437
[TBL] [Abstract][Full Text] [Related]
20. Generation of the novel monoclonal antibody against TLS/EWS-CHOP chimeric oncoproteins that is applicable to one of the most sensitive assays for myxoid and round cell liposarcomas.
Oikawa K; Ishida T; Imamura T; Yoshida K; Takanashi M; Hattori H; Ishikawa A; Fujita K; Yamamoto K; Matsubayashi J; Kuroda M; Mukai K
Am J Surg Pathol; 2006 Mar; 30(3):351-6. PubMed ID: 16538055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
